NZ332412A - use of interleuklin-10 for treating or preventing ischemia-reperfusion injury - Google Patents

use of interleuklin-10 for treating or preventing ischemia-reperfusion injury

Info

Publication number
NZ332412A
NZ332412A NZ332412A NZ33241297A NZ332412A NZ 332412 A NZ332412 A NZ 332412A NZ 332412 A NZ332412 A NZ 332412A NZ 33241297 A NZ33241297 A NZ 33241297A NZ 332412 A NZ332412 A NZ 332412A
Authority
NZ
New Zealand
Prior art keywords
treating
reperfusion injury
interleuklin
preventing ischemia
ischemia
Prior art date
Application number
NZ332412A
Inventor
James M Seeger
Timothy R S Harward
Satwant K Narula
Lyle L Moldawer
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ332412A publication Critical patent/NZ332412A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2066IL-10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)

Abstract

The use of IL-10 for the manufacture of a medicament for treating or preventing ischemia-reperfusion injury. The injury can be caused by a major organ transplant, surgical repair of a major organ or repair of an aneurysm.
NZ332412A 1996-05-02 1997-05-01 use of interleuklin-10 for treating or preventing ischemia-reperfusion injury NZ332412A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64185996A 1996-05-02 1996-05-02
PCT/US1997/006809 WO1997040849A1 (en) 1996-05-02 1997-05-01 Method for treating or preventing ischemia-reperfusion injury

Publications (1)

Publication Number Publication Date
NZ332412A true NZ332412A (en) 2000-05-26

Family

ID=24574163

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ332412A NZ332412A (en) 1996-05-02 1997-05-01 use of interleuklin-10 for treating or preventing ischemia-reperfusion injury

Country Status (9)

Country Link
EP (1) EP0906117A1 (en)
JP (1) JP2000509073A (en)
KR (1) KR20000065178A (en)
AU (1) AU721943B2 (en)
BR (1) BR9709752A (en)
CA (1) CA2253313A1 (en)
IL (1) IL126657A0 (en)
NZ (1) NZ332412A (en)
WO (1) WO1997040849A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
EP1140142A2 (en) 1998-12-22 2001-10-10 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
JP2003504088A (en) * 1999-02-19 2003-02-04 ザ ユニヴァーシティー オブ アイオワ リサーチ ファンデーション Diagnosis and treatment of macular degeneration
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
US20070123567A1 (en) * 2003-04-25 2007-05-31 Mitos Pharmaceuticals Inc. Prophylactic pretreatment with antioxidants
JP6999664B2 (en) 2016-10-31 2022-01-18 サムスン ライフ パブリック ウェルフェア ファウンデーション A pharmaceutical composition for the prevention or treatment of ischemic reperfusion injury containing bile acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10502249A (en) * 1994-07-05 1998-03-03 スティーノ・リサーチ・グループ・アクティーゼルスカブ Immunomodulator

Also Published As

Publication number Publication date
WO1997040849A1 (en) 1997-11-06
AU721943B2 (en) 2000-07-20
EP0906117A1 (en) 1999-04-07
JP2000509073A (en) 2000-07-18
KR20000065178A (en) 2000-11-06
BR9709752A (en) 1999-08-10
CA2253313A1 (en) 1997-11-06
IL126657A0 (en) 1999-08-17
AU2740597A (en) 1997-11-19

Similar Documents

Publication Publication Date Title
CA2207289A1 (en) Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9217578D0 (en) Surgical implants,etc
PL343495A1 (en) Heterocyclically substituted amides used as calpain inhibitors
MX9700538A (en) Use of droloxifene for the treatment of cardiovascular diseases.
AU1826700A (en) Radiopaque implantable collagenous biomaterial device
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
EP0647430A3 (en) Instrument for closing trocar puncture wounds.
BG63122B1 (en) Compounds and methods for cancer treatment
EP0666057A3 (en) Surgical stapling instrument.
EP0674876A3 (en) Surgical stapling instrument.
TR199701212T1 (en) Use of alpha IL-agonists for the treatment of urinary incontinence.
DE69010764D1 (en) Procedures for surgical implants.
AU1383595A (en) Orthopaedic device, especially for the gradual correction of fractures
EP0782855A4 (en) Antiinflammatory agent for external use
CY2538B1 (en) Tetrahydropyrido compounds
DK0706348T3 (en) Surgical instrument especially for dental surgery.
EP0627199A3 (en) Surgical needle-suture attachment for controlled suture release.
GR3034761T3 (en) Methods of enhancing wound healing and tissue repair.
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
EP0615728A3 (en) Orthopaedic reconstruction plate.
EP0634146A3 (en) Surgical instrument for ablating tissue.
EP1115279A4 (en) Methods for sterilizing cyanoacrylate compositions
DE69513324D1 (en) L-lysyl-glycyl-L-histidine and corresponding pharmaceutical compositions for wound healing
MX9700624A (en) Imidazopyridine-azolidinones.
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis